Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 08

2305P - Next-generation sequencing-based regression algorithm to determine homologous recombination deficiency scores in a pan-cancer cohort

Date

21 Oct 2023

Session

Poster session 08

Topics

Translational Research;  Genetic and Genomic Testing

Tumour Site

Presenters

Sejin Kim

Citation

Annals of Oncology (2023) 34 (suppl_2): S1152-S1189. 10.1016/S0923-7534(23)01927-0

Authors

S. Kim1, M. Han2, E. Oh2, Y.J. Choi3, S. Bak4

Author affiliations

  • 1 Obgyn, The Catholic University of Korea - Seoul St. Mary's Hospital - Catholic Medical Center, 06591 - Seoul/KR
  • 2 Division Of Life Sciences, College Of Life Sciences And Bioengineering, Incheon National University, 22012 - Incheon/KR
  • 3 Gynecologic Oncology, The Catholic University of Korea - College of Medicine, 06591 - Seoul/KR
  • 4 Gynecologic Oncology, The Catholic University of Korea - Bucheon St. Mary's Hospital, 420-717 - Bucheon/KR

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 2305P

Background

Homologous recombination deficiency (HRD) inhibits double strand breaks from being repaired in DNA, leading to cancer cells failing to recover themselves and cell death. Previous studies found that HRD-positive ovarian cancer patients had more significant clinical benefits from poly ADP-ribose polymerase inhibitors (PARPi) treatment. For accurate detection of HRD, next-generation sequencing (whole exome, whole genome) was used to identify large-scale genomic aberrations including telomeric allelic imbalance (HRD-TAI), loss of heterozygosity profiles (HRD-LOH), and large-scale state transitions (HRD-LST). So far, many studies (HRDetect, SigMA, CHORD and shallowHRD) have been conducted to accurately determine HRD in a pan-cancer cohort. As the study progressed, it has been revealed that PARPi is effective when applied to patients with HRD in ovarian cancer, breast cancer, prostate cancer, and pancreatic cancer. To develop an algorithm accurately predicting HRD score in patients with ovarian cancer, breast cancer, prostate cancer, and pancreatic cancer utilizing a machine learning algorithm.

Methods

We used whole-genome sequencing (WGS) data of 710 samples from 309 patients, whole-exome sequencing (WES) data of 4,650 samples from 2,193 patients from the pan-cancer cohort of the TCGA (TCGA-OV, TCGA-BRCA, TCGA-PRAD, and TCGA-PAAD). The HRD-TAI/HRD-LST/HRD-LOH scores were calculated through structural variation analyses. After data cleaning processes, machine-learning models were trained and tested on 228 out of 2,502 samples, and validation was performed on 1,248 out of 2,502 samples from the TCGA dataset.

Results

To assess the performance of the machine-learning regressor, the concordance between predictions and annotations was quantified by calculating the R squared (R2). As a result of training using machine learning algorithm, we achieved a high R2 (0.904) with a RMSE (root mean squared error) score (7.649) for a pan-cancer cohort.

Conclusions

Our regressor was robust and accurate when applied to 4 cancer types. Using our systematic pan-cancer analysis, we found novel insights into the mechanisms of HRD across cancer types with potential contribution to clinical practice.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.